Treatment of psoriasis on the face with calcitriol ointment

Korean Journal of Dermatology

Volumn 43, Issue 11, 2005, Pages 1461-1467

  Jo, Seong Jin ^a   Yoon, Hyun Sun ^a   Youn, Jai Il ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Calcitriol; Facial psoriasis

Indexed keywords

CALCITRIOL; CORTICOSTEROID DERIVATIVE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG FORMULATION; DRUG TOLERABILITY; ERYTHEMA; FOLLOW UP; HUMAN; OINTMENT; PSORIASIS; SCORING SYSTEM; SKIN ATROPHY; SKIN EXFOLIATION; SKIN PRURITUS; SOUTH KOREA; SYSTEMIC DISEASE; TELANGIECTASIA; TREATMENT OUTCOME; TREATMENT RESPONSE; UNIVERSITY HOSPITAL;

EID: 33744947789     PISSN: 04944739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Faber EM, Nall L. Epidemiology in psoriasis research. Hawaii Med J 1982;41:430-442
2. Nyfors A, Lemholt K. Psoriasis in children. A short review and a survey of 245 patients. Br J Dermatol 1975;92:437-442
3. Harrison PV, Walker GB. Facial psoriasis. Clin Exp Dermatol 1985;10:41-44
4. Park JY, Lim JH, Choe YB, Youn JI. Facial psoriasis: Comparision of patients with and without facial involvement. J Am Acad Dermatol 2004;50:582-584
5. Greaves M, Weinsten G. Treatment of psoriasis. N Engl J Med 1995;332:581-588
6. Stoughton RB, Cornell RC. Corticosteroids. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. New York: McGraw-Hill, 1993:2846-2850
7. Murdoch D, Clissold SP. Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 1992;43:415-429
8. Langner A, Verjans H, Stapor V, Mol M. 1 α, 25-dihydroxyvitamin D3 (calcitriol) ointment in psoriasis. J Dermatol Treat 1992;3:177-180
9. Langner A, Ashton P, van de Kerkhof PCM, Verjans H. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis. Br J Dermatol 1996;135:385-389
10. Ortonne JP, Humbert P, Nicolas JF et al. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3μg g-1 ointment and calcipotriol 50μg g-1 ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003;148:326-333
11. Faber EM. Facial psoriasis. Cutis 1992;50:25-28
12. Bernhard JD. Is facial involvement a sign of severe psoriasis? Clin Exp Dermatol 1985;10:500-501
13. Fullerton SH, Orenberg EK. Facial Involvement as a marker of severe psoriasis. Cutis 1987;40:309-310
14. Jo SJ, Park JY, Youn JI. Clinical experience with 0.25 % prednicarbate cream in patients with facial psoriasis. J Korean Society for Psoriasis 2004;1:27-33
15. Freeman AK, Linowski GJ, Brady C et al. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003;48:564-568
16. Langner A, Stapor W, Ambroziak M. Vitamin D3 metabolites and analogues in the treatment of scalp psoriasis. J Dermatol Treat 1998;9:S41-45
17. Kragballe K. Vitamin D and derivatives. In: Dubertret L. editor. Psoriasis. Brescia: ISED, 1994:123-134
18. Gribetz C, Ling M, Lebwohl M et al. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol 2004;51:731-738.
19. Yamamoto T, Nishioka K. Topical tacrolimus: an effective therapy for facial psoriasis. Eur J Dermatol 2003;13:471-473